-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Axitinib SR in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axitinib SR in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axitinib SR in Wet (Neovascular / Exudative)...
-
Product Insights
NewCorneal Edema – Drugs In Development, 2024
Empower your strategies with our Corneal Edema – Drugs In Development, 2024 report and make more profitable business decisions. Corneal edema is the swelling of the cornea due to the accumulation of extracellular fluid in epithelium and stroma resulting in loss of corneal transparency. The Corneal Edema drugs in development market research report provide comprehensive information on the therapeutics under development for Corneal Edema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA),...
-
Product Insights
NewMeibomian Blepharitis – Drugs In Development, 2024
Empower your strategies with our Meibomian Blepharitis – Drugs In Development, 2024 report and make more profitable business decisions. Meibomian blepharitis or Meibomian gland dysfunction (MGD) is a condition that causes low-grade inflammation of the eyelids. It can also lead to obstruction of the oil glands in the eyelid. It is caused by high cholesterol and triglycerides, allergic conjunctivitis and other eye diseases, inflamed or damaged eyelid or cornea, bacterial infection, and autoimmune diseases like rosacea, lupus, rheumatoid arthritis, and Sjögren's...
-
Sector Analysis
Ophthalmic Lasers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Ophthalmic Lasers Market Report Overview The ophthalmic lasers market size was $1.12 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Ophthalmic lasers create a uniform and coherent light that can be continuous or pulsed. The devices are used in treating a wide spectrum of diseases involving both the anterior and posterior segments of the eye for correcting refractive disorders. Ophthalmic Lasers Market Outlook, 2023-2033 ($ Billion) Â Buy the Full Report...
-
Product Insights
NewBlepharitis – Drugs In Development, 2024
Empower your strategies with our Blepharitis – Drugs In Development, 2024 report and make more profitable business decisions. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, and occasionally allergies. Blepharitis signs and symptoms include red and watery eyes, itchy eyelids, and sensitivity to light. Treatment includes antibiotics, lubricating eye drops, and steroid eye drops or ointments. The Blepharitis drugs in development...
-
Sector Analysis
Glaucoma Surgery Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Glaucoma Surgery Devices Market Report Overview The glaucoma surgery devices market size was $373.2 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. Glaucoma...
-
Product Insights
NewCorneal Dystrophy – Drugs In Development, 2024
Empower your strategies with our Corneal Dystrophy – Drugs In Development, 2024 report and make more profitable business decisions. Corneal dystrophy (CD) is defined as a collection of rare hereditary non-inflammatory disorders of abnormal deposition of substances in the cornea. The material may cause the cornea to lose its transparency and can cause loss of vision or blurred vision. Corneal dystrophies can appear at any age and men and women are equally affected by most corneal dystrophies. The symptoms of corneal...
-
Product Insights
NewFuchs Endothelial Corneal Dystrophy (FECD) – Drugs In Development, 2024
Empower your strategies with our Fuchs Endothelial Corneal Dystrophy (FECD) – Drugs In Development, 2024 report and make more profitable business decisions. Fuchs endothelial corneal dystrophy (FECD) is characterized by progressive loss of corneal endothelial cells, thickening of Descement's membrane and deposition of extracellular matrix in the form of guttae. When the number of endothelial cells becomes critically low, the cornea swells and causes loss of vision. It affects the thin layer of cells that line the back part of the...
-
Product Insights
NewUveitis – Drugs In Development, 2024
Empower your strategies with our Uveitis – Drugs In Development, 2024 report and make more profitable business decisions. Uveitis is swelling and irritation of the uvea, the middle layer of the eye. Uveitis can affect one or both eyes. Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ankylosing spondylitis, infection, or exposure to toxins. Symptoms include blurred vision, dark floating spots in the vision, eye pain, redness of the eye, and sensitivity to light. The predisposing factors...
-
Product Insights
NewMacular Edema – Drugs In Development, 2024
Empower your strategies with our Macular Edema – Drugs In Development, 2024 report and make more profitable business decisions. Macular edema is swelling or fluid retention in a specialized part of the retina called the macula. Symptoms of macular edema include blurred or wavy central vision and/or colors appear changed. There are many causes of macular edema. It is frequently associated with diabetes, where damaged blood vessels in the retina begin to leak fluids, including small amounts of blood, into the...